CAPN3 and neuroblastoma: These results corroborate the loss of both endothelial cells and vessel integrity in the neuroblastoma xenograft tumors from the mice treated with NCL-1, and illuminate a significant anti-angiogenic effect of NCL-1 in the tumor microenvironment.